4/A
Changes in Ownership
Milestone Pharmaceuticals Inc. Filed Acc 0001771207-26-000005
Options or other derivatives
- Chief Commercial Officer acquired 204,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Muller Lorenz Chief Commercial Officer | 2026-02-02 | Grant or award · Employee Stock Option (right to buy) | +204,000 | 204,000 | D: show line 1 in the form |
Loading xslF345X05/form4a-02052026_040210.xml…